Abstract
Beta-dystroglycan is expressed in a wide variety of tissues and has generally been reported with an Mr of 43 kDa, sometimes accompanied with a 31 kDa protein assumed to be a truncated product. This molecule was recently identified as the anomalous beta-dystroglycan expressed in various carcinoma cell lines. We produced and characterized a G5 polyclonal antibody specific to beta-dystroglycan that is directed against the C-terminal portion of the molecule. We provide evidence that beta-dystroglycan may vary in size and properties by studying different Xenopus tissues. Besides normal beta-dystroglycan with an Mr of 43 kDa in smooth and cardiac muscle and sciatic nerve extracts, we found it in skeletal muscle and brain proteins with an Mr of 38 and 65 kDa, respectively. Glycosylation properties and proteolytic susceptibilities of these different beta-dystroglycans are analysed and compared in this work. Crosslinking experiments with various beta-dystroglycan preparations obtained from skeletal and cardiac muscles and brain gave rise to specific new covalent products with Mr of 125 kDa (doublet band), or 120 and 130 kDa, or 140 and 240 kDa, respectively. We provide evidence, using various similar beta-dystroglycan preparations, that the immunoprecipitation procedure with G5 specific polyclonal antibody allows consistent pelleting of various dystrophin-family isoforms. Skeletal muscles from Xenopus reveals the presence of two distinct beta-dystroglycan complexes, one with dystrophin and another one which involves alpha-dystrobrevin. Cardiac muscle and brain from Xenopus are shown to contain three beta-dystroglycan complexes related to various dystrophin-family isoforms. Dystrophin or alpha-dystrobrevin or Dp71 were found in cardiac muscle and dystrophin or Dp180 or Up71 in brain. This variability in the relationship between beta-dystroglycan and dystrophin-family isoforms suggests that each protein – currently known as dystrophin associated protein – could not be present in each of these complexes.
Similar content being viewed by others
References
Araishi K, Sasaoka T, Imamura M, Noguchi S, Hama H, Wakaba-yashi E, Yoshida M, Hori T and Ozawa E (1999) Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-de cient mice. Hum Molec Genet 8: 1589–1598.
Augier N, Leger J, Robert A, Pons F, Leger JJ and Mornet D (1992) Proteolytic susceptibility of the central domain in chicken gizzard and skeletal muscle dystrophin. Biochim Biophys Acta 1138: 297–304.
Blake DJ (2002) Dystrobrevin dynamics in muscle-cell signalling: a possible target for therapeutic intervention in Duchenne muscular dystrophy? Neuromuscular Disord. 12: S110–S117.
Blake DJ, Love DR, Tinsley J, Morris GE, Turley H, Gatter K, Dickson G, Edwards YH and Davies KE (1992) Characterization of a 4. 8 kb transcript from Duchenne muscular dystrophy locus expressed in schwannoma cells. Hum Molec Genet 1: 103–109.
Blake DJ, Nawrotzki R, Loh LY, Gorecki DC and Davies KE (1998) Beta-dystrobrevin, a member of the dystrophin-related protein family. Proc Natl Acad Sci USA 95: 241–246.
Blake DJ, Nawrotzki R, Peters MF, Froehner SC and Davies KE (1996) Isoform diversity of dystrobrevin, the murine 87 kDa postdynaptic protein. J Biol Chem 273: 7802–7810.
Blake DJ, Tinsley JM, Davies KE, Knight AE, Winder SJ and Kendrick-Jones J (1995) Coiled-coil regions in the carboxy-terminal domains of dystrophin and related proteins: potentials fro protein–protein interactions. TIBS 20: 133–135.
Chaussepied P, Mornet D and Kassab R (1986) Nucleotide trapping at the ATPase site of myosin subfragment-1 by a new interthiol cross-link. Proc Natl Acad Sci USA 83: 2037–2041.
Cote PH, Moukhles H and Carbonetto S (2002) Dystroglycan is not required for localisation of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha7B expression and caveolin-3 distribution. J Biol Chem 277: 4672–4679.
Crawford GE, Faulkner JA, Crosbie RH, Campbell KP, Froehner SC and Chamberlain JS (2000) Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. J Cell Biol 150: 805–808.
Durbeej M, Henry DH, Ferletta M, Campbell KP and Ekblom P (1998) Distribution of dystroglycan in normal adult mouse tissues. JHistochem Cytochem 46: 449–457.
Elzinga M and Phelan JJ (1984) F-actin is intramolecularly cross-linked by N-N′-p-phenylenedimaleimide through lysine-191 and cysteine 374. Proc Natl Acad Sci USA 81: 6599–6602.
Ervasti JM, Burwell AL and Geissler AL (1997) Tissue-specific heterogeneity in alpha-dystroglycan is a latent receptor for vicia villosa agglutinin b4 naked by sialic acid modification. J Biol Chem 272:, 22,315–22,321.
Fabbrizio E, Leger J, Leger JJ and Mornet D (1993) Dystrophin and dystrophin-related protein expression in Torpedo marmorata electric organ. Neuroscience Letters 155: 51–56.
Fabbrizio E, Nudel U, Hugon G, Robert A, Pons F and Mornet D (1994) Characterization and localization of a 77 kDa protein related to the dystrophin gene family. Biochem J 299: 359–365.
Gieseler K, Grisoni K, Mariol M-C and Segala L (2002) Overexpres-sion of dystrobrevin delays locomotion defects and muscle degeneration in a dystrophin-deficient caenorhabditis elegans.Neuromuscular Disord 12: 371–377.
Gorecki DC and Barnard EA (1995) Specific expression of G-dystrophin (Dp71) in the brain. Neuroreport 6: 893–896.
Gorecki DC, Derry JMJ and Barnard EA (1994) Dystroglycan: brain localization and chromosome mapping in mouse. Hum Molec Genet 9: 1589–1597.
Gorecki D, Geng Y, Thomas K, Hunt SP, Barnard EA and Barnard PJ (1991) Expression of the dystrophin gene in mouse and rat brain. Neuroreport 2: 773–776.
Gorecki DC, Monaco AP, Derry JMJ, Walker AP, Barnard EA and Barnard PJ (1992) Expression of four alternative dystrophin transcripts in brain regions regulated by diffirent promoters. Hum Molec Genet 7: 505–510.
Huang, X, Poy F, Zhang R, Joachimiak A, Sudol M and Eck MJ (2000) Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan. Nat Struct Biol 7: 634–638.
Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW and Campbell KP (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696–702.
Ibraghimov-Beskrovnaya O, Milatovich A, Ozcelik T, Yang B, Koepnick K, Francke U and Campbell KP (1993) Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Molec Genet 2: 1651–1657.
Ilsley JL, Sudol M and Winder SJ (2001) The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation. Cell Signall 13: 625–632.
James M, Nuttall A, Ilsley JL, Ottersbach K, Tinsley JM, Sudol Mand Winder SJ (2000) Adhesion-dependent tyrosine phosphorylation of Beta-dystroglycan regulates its interaction with utrophin. J Cell Sci 113: 1717–1726.
Jung D, Yang B, Meyer J, Chamberlain JS and Campbell KP (1995) Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem 270: 27, 305–27,310.
Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C and Kunkel LM (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMDgene in normal and affected individuals. Cell 50: 509–517.
Lasasso C, Tommaso F, Sgambato A, Ardito R, Cittadini A, Giardina B, Petrucci TC and Brancaccio A (2000) Anomalous dystroglycan in carcinoma cell lines. FEBS Letters 484: 194–198.
Lederfein D, Levy Z, Augier N, Mornet D, Morris G, Fuchs O, Yaffe D and Nudel U (1992) A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc Natl Acad Sci USA 89: 5346–5350.
Leschziner A, moukhles H, Lindenbaum M, Gee SH, Butterworth J, Campbell KP and Carbonetto S (2000) Neural regulation of alpha-dystroglycan biosynthesis and glycosylation in skeletal muscle. J Neurochem 74: 70–80.
Lidov HGW (1996) Dystrophin in the nervous system. Brain Pathol 6: 63–77.
Lidov HGW, Byers TJ and Kunkel LM (1993) The distribution of dystrophin in the murine central nervous system: an immunocy-tochemical study. Neuroscience 54: 167–187.
Lidov HGW, Byers TJ, Walkin SC and Kunkel LM (1990) Localiza-tion of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 348: 725–728.
Lidov HGW, Selig S and Kunkel LM (1995) Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum Molec Genet 4: 329–335.
Matsumara K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP (1992) Association of dystroglycan-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360: 588–591.
McDearmon EL, Combs AC and Ervasti JM (2001) Diffirential Vicia villosa agglutinin reactivity identifies three distinct dystroglycan complexes in skeletal muscle. J Biol Chem 276: 35, 35,078–35,086.
Moukhles H and Carbonetto S (2001) Dystroglycan contributes to the formation of multiple dystrophin-like complexes in brain. J Neu-rochem 78: 824–834.
Nawrotzki R, Loh NY, Ruegg MA, Davies KE and Blake DJ (1988) Characterization of alpha-dystrobrevin in muscle. J Cell Sci 111: 2595–2605.
Pereboev AV, Naseem A, Man NT and Morris GE (2001) Epitopes in the interacting regions of beta-dystroglycan (Ppxy motif) and dystrophin (WW domain). Biochim Biophys Acta 1527: 54–60.
Pons F, Robert A, Fabbrizio E, Hugon G, Califano JPC, Fehrentz JA, Martinez J and Mornet D (1994) Utrophin localization in normal and dystrophin-defficient heart. Circulation 90: 369–374.
Rivier F, Robert A, Hugon G and Mornet D (1997) Different utrophin and dystrophin properties related to their vascular smooth muscle distributions. FEBS Lett 408: 94–98.
Royuela M, Hugon G, Rivier F, Fehrentz JA, Martinez J, Paniagua R and Mornet D (2001) Presence of invertebrate dystrophin-like products in obliquely striated muscle of the leech, Potobdella muricata (Annelida, Huridinea). Histochem J 33: 135–139.
Royuela M, Hugon G, Rivier F, Fehrentz JA, Martinez J, Paniagua R and Mornet D (2001) Variations in dystrophin complex in red and white caudal muscles from Torpedo marmorata. J Histochem Cytochem 49: 857–865.
Sadoulet-Puccio HM, Rajala M and Kunkel LM (1997) Dystrobrezvin and dystrophin: an interaction through coiled-coil motifs. Proc Natl Acad Sci USA 94: 12, 12,413–12,418.
Sciandra F, Schneider M, Giardina B, Baumgartner S, Petrucci TC and Brancaccio A (2001) Identification of the beta-dystroglycan binding epitope within the C-terminal region of alpha-dystrogly-can. Eur J Biochem 268: 4590–4597.
Stedman H, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT and Kelly AM (1991) The mdx mouse diaphragm reproduces the degenera-tive changes of Duchenne muscular dystrophy. Nature 352: 536–539.
Tiam M, Jacobson C, Gee SH, Campbell KP, Carbonetto S and Jacker M(1996) Dystroglycan in the cerebellum is a laminin alpha-2 chain binding protein at the glial-vascular interface and is expressed in Purkinje cells. Eur J Neurosci 8: 2739–2747.
Wells JA and Yount RG (1979) Active site trapping of nucleotides by cross-linking two sulfhydryls in myosin subfragment-1. Proc Natl Acad Sci USA 76: 4966–4970.
White O, Eisen JA, Heidelberg JF, et al. (1999) Genome sequence of the radioresistant bacterium Deinococcus radiodurans R1. Science 286: 1571–1577.
Wilson J, Putt W, Jimenez C, Edwards YH (1999) Up 71 and Up140, two novel transcripts of utrophin that are homologous of short forms of dystrophin. Hum Molec Genet 8: 1271–1278.
Winder S (1997) The membrane-cytoskeleton interface: the role of dystrophin and utrophin. J Muscle Res Cell Motil 18: 617–629.
Winder S (2001) The complexity of dystroglycan. Trends Biochem Sciences 26: 118–123.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Royuela, M., Chazalette, D., Hugon, G. et al. Formation of multiple complexes between beta-dystroglycan and dystrophin family products. J Muscle Res Cell Motil 24, 387–397 (2003). https://doi.org/10.1023/A:1027309822007
Issue Date:
DOI: https://doi.org/10.1023/A:1027309822007